Mochi Healths CEO avoids questions, no response from Aequita NBC Bay Areas Investigative Unit has tried to speaking with someone at Aequita and Myra Ahmad about these allegations since April, but we havent received a response
[1] A similar medication, tirzepatide, is available as Mounjaro, approved for treating type 2 diabetes, and Zepbound, approved for weight management
There is no current evidence for primary prevention, that is, direct risk reduction in people without existing heart disease
It is more common for patients to experience dosing errors when drawing up their own medications compared to pre-filled pens or syringes, Lambson says
we strive to cultivate long-lasting relationships with our customers